NFKB1 and gastric cancer: In a further study focused on inflammation outcomes, Yang et al. [90] found that the protein expression of COX-2 and NF-κB in human gastric cancer (MKN45) cells were diminished after co-treatment with 5-FU (50 μmol/L) and curcumin (25 μmol/L).